CytoMed Therapeutics Limited Receipts From Royalties Fees Commissions And Other Revenue
CytoMed Therapeutics Limited (GDTC) had Receipts From Royalties Fees Commissions And Other Revenue of SGD 10.31 million as of 2023-04-18, per its 20-F filed 2024-04-22.
Discontinued › Notes
ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue · last filed 2024-04-22
- 2023-04-18: Receipts From Royalties Fees Commissions And Other Revenue 10.31M SGD.
SGD
| Period end | Receipts From Royalties Fees Commissions And Other Revenue |
|---|---|
| 2023-04-18 | 10.31M SGD 20-F · filed 2024-04-22 |
USD
| Period end | Receipts From Royalties Fees Commissions And Other Revenue |
|---|---|
| 2023-04-18 | $7.81M 20-F · filed 2024-04-22 |